Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Selecting patients for discussion of the ICD as primary prevention for sudden death in heart failure.

Stevenson LW, Desai AS.

J Card Fail. 2006 Aug;12(6):407-12. Review.

PMID:
16911905
2.

Predictors of appropriate implantable cardioverter-defibrillator therapy during long-term follow-up of patients with coronary artery disease.

Blumer J, Wolber T, Hellermann J, Holzmeister J, Binggeli C, Duru F, Brunckhorst C.

Int Heart J. 2009 May;50(3):313-21.

3.

Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias.

Healey JS, Hallstrom AP, Kuck KH, Nair G, Schron EP, Roberts RS, Morillo CA, Connolly SJ.

Eur Heart J. 2007 Jul;28(14):1746-9. Epub 2007 Feb 5.

PMID:
17283003
4.

Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.

Ghanbari H, Dalloul G, Hasan R, Daccarett M, Saba S, David S, Machado C.

Arch Intern Med. 2009 Sep 14;169(16):1500-6. doi: 10.1001/archinternmed.2009.255.

PMID:
19752408
5.

Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.

Koller MT, Schaer B, Wolbers M, Sticherling C, Bucher HC, Osswald S.

Circulation. 2008 Apr 15;117(15):1918-26. doi: 10.1161/CIRCULATIONAHA.107.742155. Epub 2008 Apr 7.

6.

Patient selection for primary prevention ICDs--are eps shocking patients into consent?

Saxon LA.

J Card Fail. 2006 Aug;12(6):413-5. No abstract available.

PMID:
16911906
7.

Cost of preimplantation cardiac imaging in patients referred for a primary-prevention implantable cardioverter-defibrillator.

Krahn AD, Hoch JS, Rockx MA, Leong-Sit P, Gula LJ, Yee R, Skanes AC, Klein GJ.

Am J Cardiol. 2008 Sep 1;102(5):588-92. doi: 10.1016/j.amjcard.2008.04.067. Epub 2008 Jul 12.

PMID:
18721517
8.

The future of implantable defibrillator and cardiac resynchronization therapy trials.

Saksena S, Nagarakanti R.

J Interv Card Electrophysiol. 2008 Oct;23(1):29-39. doi: 10.1007/s10840-008-9302-6. Epub 2008 Aug 29. Review.

PMID:
18758929
9.
10.

Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death.

Das M.

Expert Rev Cardiovasc Ther. 2009 Feb;7(2):181-95. doi: 10.1586/14779072.7.2.181. Review.

PMID:
19210214
11.

Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial.

Russo AM, Poole JE, Mark DB, Anderson J, Hellkamp AS, Lee KL, Johnson GW, Domanski M, Bardy GH.

J Cardiovasc Electrophysiol. 2008 Jul;19(7):720-4. doi: 10.1111/j.1540-8167.2008.01129.x. Epub 2008 Mar 26.

PMID:
18373605
12.
13.

Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.

Lin G, Nishimura RA, Gersh BJ, Phil D, Ommen SR, Ackerman MJ, Brady PA.

Heart. 2009 May;95(9):709-14. doi: 10.1136/hrt.2008.150656. Epub 2009 Mar 11.

PMID:
19282314
14.

Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death.

Cuculich PS, Sánchez JM, Kerzner R, Greenberg SL, Sengupta J, Chen J, Faddis MN, Gleva MJ, Smith TW, Lindsay BD.

Pacing Clin Electrophysiol. 2007 Feb;30(2):207-13.

PMID:
17338717
15.

Racial disparity in the utilization of implantable-cardioverter defibrillators among patients with prior myocardial infarction and an ejection fraction of <or=35%.

Thomas KL, Al-Khatib SM, Kelsey RC 2nd, Bush H, Brosius L, Velazquez EJ, Peterson ED, Gilliam FR.

Am J Cardiol. 2007 Sep 15;100(6):924-9. Epub 2007 Jun 27.

PMID:
17826371
16.

Implanted cardioverter defibrillators for the prevention of sudden death.

Dorian P, Talajic M, Tang A.

Can J Cardiol. 2005 May;21 Suppl A:31A-36A. Review.

PMID:
15953942
17.

Use of beta-blockers in patients with an implantable cardioverter defibrillator.

LaPointe NM, Stafford JA, Pappas PA, Al-Khatib SM, Anstrom KJ.

Ann Pharmacother. 2009 Jul;43(7):1189-96. doi: 10.1345/aph.1M140. Epub 2009 Jun 30.

PMID:
19567655
18.

Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.

Ding L, Hua W, Niu H, Chen K, Zhang S.

Europace. 2008 Sep;10(9):1034-41. doi: 10.1093/europace/eun150. Epub 2008 Jun 16. Review.

PMID:
18559335
19.

Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study.

Bellocci F, Biasucci LM, Gensini GF, Padeletti L, Raviele A, Santini M, Giubilato G, Landolina M, Biondi-Zoccai G, Raciti G, Sassara M, Castro A, Kheir A, Crea F.

J Cardiovasc Med (Hagerstown). 2007 Apr;8(4):293-9.

PMID:
17413310
20.

Characteristics of ventricular tachyarrhythmias occurring in ischemic versus nonischemic patients implanted with a biventricular cardioverter-defibrillator for primary or secondary prevention of sudden death.

Boriani G, Gasparini M, Lunati M, Santini M, Landolina M, Vincenti A, Curnis A, Bocchiardo M, Padeletti L, Biffi M, Allaria L, Denaro A; InSync ICD Italian Registry Investigators.

Am Heart J. 2006 Sep;152(3):527.e1-11.

PMID:
16923425

Supplemental Content

Support Center